SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genta, Inc. (GNTA)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1870 44 0 GNTA
Emcee:  John Nobrega Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1670Two Studies Show Activity of Genasense(TM) in Acute Leukemia 9 Dec 2002, 08:02abob zagorin-12/9/2002
1669Recently took a small position in Genta for a couple of reasons. Their reports oBulbaMan-12/6/2002
1668Annual Meeting of the American Society of Hematology Meeting Highlights Primacy bob zagorin-12/5/2002
1667Leading Cancer Researcher, Jerome E. Groopman, Appointed to Genta's Board ofbob zagorin-11/27/2002
1666Broad Genomic and Anticancer Activity of Genta's CRE-Decoy Aptamer Presentedbob zagorin-11/26/2002
1665Clinical Data Presented for Genasense(TM) Plus Chemotherapy for Newly Diagnosed bob zagorin-11/22/2002
1664Genta Chief Defends FDA Robert Langreth, 11.06.02, 12:00 PM ET NEW YORK - Drubob zagorin-11/8/2002
1663Coverage Reiterated * Company Symbol Brokerage Firm Reiterated Rating: Target bob zagorin-11/8/2002
1662Genta Announces 3rd Quarter 2002 Financial Results and Highlights Conference Calbob zagorin-11/7/2002
1661NCI Initiates Trials of Genasense(TM) in Patients with Colorectal Cancer And Othbob zagorin-11/6/2002
1660Genta Incorporated Announces Conference Call To Discuss Third Quarter 2002 Earnibob zagorin-10/31/2002
1659NCI Initiates Trial of Genasense(TM) Plus Rituxan In Patients With Non-Hodgkin&#bob zagorin-10/30/2002
1658Genta Appoints Senior Pharmaceutical Industry Executive, William P. Keane, as Chbob zagorin-10/28/2002
1657Genta Incorporated to Present at Techvest Healthcare Conference BERKELEY HEIGHTbob zagorin-10/17/2002
1656Genta Reiterates Company Progress and Timelines for Genasense(TM) BERKELEY HEbob zagorin-10/8/2002
1655GNTA cracking, any news?? eom.jimsioi-10/8/2002
165410/2/2002 -- Investigators at Washington University School of Medicine in St. Lokeokalani'nui-10/3/2002
1653Lymphoma & Myeloma Conference Highlights Importance of Genasense(TM) Target bob zagorin-10/3/2002
1652Genta Announces the Initiation of NCI/CALGB Trial of Genasense(TM) Plus Gleevec(bob zagorin-10/2/2002
1651cool interview...http://www.healthtalk.com/oncology/horiz/rai/index.html ......sscotty-10/1/2002
1650Company News for GNTA Genta Incorporated To Present At UBS Warburg Life Sciencbob zagorin-10/1/2002
1649cool post from message board by rai_gl_208..... "NCI wouldn't continue scotty-9/25/2002
1648some dated articles....http://www.google.com/search?hl=cn&ie=ISO-8859-1&scotty-9/24/2002
1647Genta Initiates Clinical Trial of Genasense(TM) Plus Thalidomide In Patients ...bob zagorin-9/23/2002
1646Short Interest Declining Aug 15, 2002 From Nasdaq. Settlement Date ShortJohn William Anderson-9/11/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News